Jane Street’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-90,855
| Closed | -$3.13M | – | 8519 |
|
|
2020
Q3 | $3.13M | Buy |
90,855
+69,690
| +329% | +$1.48M | ﹤0.01% | 2387 |
|
|
2020
Q2 | $354K | Buy |
+21,165
| New | +$359K | ﹤0.01% | 5594 |
|
|
2020
Q1 | – | Sell |
-29,083
| Closed | -$743K | – | 6306 |
|
|
2019
Q4 | $974K | Buy |
29,083
+18,116
| +165% | +$506K | ﹤0.01% | 2822 |
|
|
2019
Q3 | $230K | Buy |
+10,967
| New | +$224K | ﹤0.01% | 4486 |
|
|
2018
Q4 | – | Sell |
-19,072
| Closed | -$520K | – | 6069 |
|
|
2018
Q3 | $520K | Buy |
+19,072
| New | +$539K | ﹤0.01% | 3580 |
|
|
2018
Q2 | – | Sell |
-16,741
| Closed | -$512K | – | 5886 |
|
|
2018
Q1 | $533K | Buy |
+16,741
| New | +$589K | ﹤0.01% | 3417 |
|
|
2015
Q4 | – | Sell |
-9,943
| Closed | -$252K | – | 4634 |
|
|
2015
Q3 | $252K | Buy |
+9,943
| New | +$232K | ﹤0.01% | 2959 |
|
Jane Street's AIMT Position: Q4 2020 in Review
Jane Street sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 90,855 shares — an estimated $3.13M sold.
Jane Street first reported a position in AIMT in Q3 2015 and held it in 7 quarters. The position peaked at $3.13M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- Jane Street reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- Jane Street sold 90,855 Aimmune Therapeutics shares in Q4 2020, an estimated $3.13M.
- Jane Street first reported a position in Aimmune Therapeutics in Q3 2015 and held it in 7 quarters.
- Jane Street's Aimmune Therapeutics position peaked at $3.13M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.